INC Research moves into late phase

By Kirsty Barnes

- Last updated on GMT

Related tags Pharmacology Clinical trial Contract research organization

INC Research has expanded its late phase contract research
capabilities with the purchase of a contract research organisation
(CRO) in Philadelphia, US.

The acquired firm, Pharmaceutical Resource Corporation, specialises in Phase III-B and IV trials, as well as pharmacovigilance and drug safety - areas where INC had been looking to gain new expertise.

"With the addition of PRC, we are able to offer our customers a greater depth of late-phase clinical trial experience,"​ said James Ogle, INC's chief executive officer.

Pharmaceutical companies are often required to carry out late phase studies by the Food and Drug Administration (FDA) after a drug has received approval in order to gather more clinical information.

With several recent high profile concerns over drug safety, such as in the case of Vioxx, these studies are being requested by the FDA more and more often and the late phase CRO business is booming.

The new company was bought for an undisclosed sum and brings INC's sites in the US to a total of five.

INC has been going through a period of expansion of late, moving into new US headquarters in Raleigh where it is currently in the process of adding 100 new workers to the site.

The company also opened new offices in France, Russia and the Ukraine earlier this year, as well as acquiring an oncology firm last December.

Related topics Clinical Development Phase III-IV

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more